References
- Edwards IR, Aronson J. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–1259.
- Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf. 2012;35(9):769–781.
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–1205.
- Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies. Drug Saf. 2015;38(5):437–453.
- Letrilliart L, Hanslik T, Biour M, et al. Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study. Drug Saf. 2001;24(10):781–792.
- González-Rubio F, Calderón-Larrañaga A, Poblador-Plou B, et al. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study. Pharmacoepidemiol Drug Saf. 2011;20(12):1287–1294.
- Layton D, Sinclair HK, Bond CM, et al. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK. Pharmacoepidemiol Drug Saf. 2002;11(6):503–513.
- Krska J, Jones L, McKinney J, et al. Medicine safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098–1103.
- Jarernsiripornkul N, Patsuree A, Krska J. Survey of patients’ experiences and their certainty of suspected adverse drug reactions. Int J Clin Pharm. 2015;37(1):168–174.
- Elkalmi R, Hassali MA, Al-Lela OQ, et al. Adverse drug reactions reporting: Knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci. 2013;5(3):224–228.
- Berry DC, Michas IC, Gillie T, et al. What do patients want to know about their medicines, and what do doctors want to tell them?: A comparative study. Psychol Health. 1997;12(4):467–480.
- Grime J, Blenkinsopp A, Raynor DK, et al. The role and value of written information for patients about individual medicines: a systematic review. Health Expect. 2007;10(3):286–298.
- Phueanpinit P, Jarernsiripornkul N, Pongwecharak J, et al. Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2014;36(6):1205–1212.
- Gomes E, Cardoso MF, Praca F, et al. Self-reported drug allergy in general adult Portuguese population. Clin Exp Allergy. 2004;34(10):1597–1601.
- Stewart D, Helms P, McCaig D, et al. Monitoring adverse drug reactions in children using community pharmacies: a pilot study. Br J Clin Pharmacol. 2005;59(6):677–683.
- Vohra S, Cvijovic K, Boon H, et al. Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS One. 2012;7(9):e45196.
- Avery AJ, Anderson C, Bond CM, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15(20):1–234.
- Anderson C, Krska J, Murphy E, et al. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol. 2011;72(5):806–822.
- Cullen G, Kelly E, Murray FE. Patients’ knowledge of adverse reactions to current medications. Br J Clin Pharmacol. 2006;62(2):232–236.
- MedDRA Maintenance and Support Services Organization. Introductory Guide to MedDRA Version 14.0. Virginia: International Federation of Pharmaceutical Manufacturers and Associations; 2011.
- ATC/DDD Index. 2015. WHO Collaborating Centre for Drug Statistics Methodology. Oslo Available from: http://www.whocc.no/atc_ddd_index/ [cited Oct 11 2015].
- Parsian N, Dunning T. Developing and Validating a Questionnaire to Measure Spirituality: A Psychometric Process. Glob J Health Sci. 2009;1(1):2–11.
- Yamane T. Statistics, An Introductory Analysis. New York: Harper and Row; 1967.
- Health Product Vigilance Center. ADR reporting 2012. Bangkok: Thai Food and Drug Administration, Ministry of Public Health; 2012
- McLernon DJ, Bond CM, Hannaford PC, et al. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals. Drug Saf. 2010;33(9):775–788.
- Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27(4):243–248.